Telomere Length Variation in Juvenile Acute Myocardial Infarction

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Russo, Alessia ^a,b   Palumbo, Luigi ^c   Fornengo, Cristina ^c   Di Gaetano, Cornelia ^a,b   Ricceri, Fulvio ^a,b   Guarrera, Simonetta ^b   Critelli, Rossana ^a,b   Anselmino, Matteo ^c   Piazza, Alberto ^a,b   Gaita, Fiorenzo ^c   Bergerone, Serena ^c   Matullo, Giuseppe ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Human Genetics Foundation   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEUKOCYTE; LEUKOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ONSET AGE; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TELOMERE HOMEOSTASIS;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; GENETIC MARKERS; GENETIC VARIATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84868673795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049206     Document Type: Article

References (37)

1. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V, (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100: 1481-1492.
2. Choudhury L, Marsh JD (1999) Myocardial infarction in young patients. Am J Med 107: 254-261. DOI S0002-9343(99)00218-1.
3. Egred M, Viswanathan G, Davis GK (2005) Myocardial infarction in young adults. Postgrad Med J 81: 741-745. DOI 81/962/741 1136/pgmj.2004.027532.
4. Fournier JA, Cabezon S, Cayuela A, Ballesteros SM, Cortacero JA, et al. (2004) Long-term prognosis of patients having acute myocardial infarction when
5. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, et al. (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105: 1541-1544.
6. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106: 661-673. DOI S0092-8674(01)00492-5.
7. Olovnikov AM (1996) Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 31: 443-448. DOI 0531556596000058.
8. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH (2001) Telomere shortening in atherosclerosis. Lancet 358: 472-473. DOI S0140-6736(01)05633-11016/S0140-6736(01)05633-1.
9. Huzen J, de Boer RA, van Veldhuisen DJ, van Gilst WH, van der Harst P (2010) The emerging role of telomere biology in cardiovascular disease. Front Biosci 15: 35-45. DOI 3604.
10. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, et al. (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369: 107-114. DOI S0140-6736(07)60071-3 1016/S0140-6736(07)60071-3.
11. Maubaret CG, Salpea KD, Jain A, Cooper JA, Hamsten A, et al. (2010) Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors. J Mol Med 88: 785-794. DOI 10.1007/s00109-010-0624-3.
12. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36: 959-969. DOI S0735109700008044.
13. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, et al. (1998) Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140: 199-270. DOI S002191509890209X.
14. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, et al. (2003) Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108: 2543-2549. DOI 10.1161/01.CIR.0000100560.46946.EA01.CIR.0000100560.46946.EA.
15. Cawthon RM, (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
16. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ (2003) White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23: 842-846. DOI 10.1161/01.ATV.0000067426.96344.3201.ATV.0000067426.96344.32.
17. Zee RY, Michaud SE, Germer S, Ridker PM (2009) Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach. Clin Chim Acta 403: 139-141. DOI S0009-8981(09)00075-810.1016/j.cca.2009.02.004.
18. Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, et al. (2008) High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Am Heart J 155: 706-711. DOI S0002-8703(07)00944-10.1016/j.ahj.2007.11.016.
19. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, et al. (2002) Acute myocardial infarction in the young-The University of Michigan experience. Am Heart J 143: 56-62. DOI S0002870302688362.
20. Imazio M, Bobbio M, Bergerone S, Barlera S, Maggioni AP, (1998) Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience. G Ital Cardiol 28: 505-512.
21. Salpea KD, Nicaud V, Tiret L, Talmud PJ, Humphries SE (2008) The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II. J Mol Med 86: 815-824. DOI 10.1007/s00109-008-0347-x.
22. Fuster JJ, Diez J, Andres V (2007) Telomere dysfunction in hypertension. J Hypertens 25: 2185-2192. DOI 10.1097/HJH.0b013e3282ef619600004872-200711000-00001.
23. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH et al. (2010) Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension 55: 1389-1397.DOI HYPERTENSIONAHA.109.14161410.1161.
24. Yang Z, Huang X, Jiang H, Zhang Y, Liu H, et al. (2009) Short telomeres and prognosis of hypertension in a chinese population. Hypertension 53: 639-645. DOI HYPERTENSIONAHA.108.123752.
25. Dehghan A, Yang Q, Peters A, Basu S, Bis JC, et al. (2009) Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2: 125-133. DOI 2/2/125 10.1161/CIRCGENETICS.108.825224.
26. Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, et al. (2001) Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37: 381-385.
27. Jeanclos E, Schork NJ, Kyvik KO, Kimura M, Skurnick JH, et al. (2000) Telomere length inversely correlates with pulse pressure and is highly familial. Hypertension 36: 195-200.
28. Shiels PG, McGlynn LM, MacIntyre A, Johnson PC, Batty GD, et al. (2011) Accelerated telomere attrition is associated with relative household income, diet and inflammation in the pSoBid cohort. PLoS One 6: e22521.
29. Dei Cas A, Spigoni V, Franzini L, Preti M, Ardigo D, et al. (2011) Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults. Nutr Metab Cardiovasc Dis.
30. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, et al. (2010) Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One 5: e8612.
31. Mainous AG 3rd, Codd V, Diaz VA, Schoepf UJ, Everett CJ,et al. (2010) Leukocyte telomere length and coronary artery calcification. Atherosclerosis 210: 262-267. DOI S0021-9150(09)00922-8 10.1016/j.atherosclerosis.2009.10.047.
32. De Meyer T, Rietzschel ER, De Buyzere ML, Langlois MR, De Bacquer D, et al. (2009) Systemic telomere length and preclinical atherosclerosis: the Asklepios Study. Eur Heart J 30: 3074-3081. DOI ehp324 10.1093/eurheartj/ehp324.
33. Wilson WR, Herbert KE, Mistry Y, Stevens SE, Patel HR, et al. (2008) Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur Heart J 29: 2689-2694. DOI ehn386 10.1093/eurheartj/ehn386.
34. Fornengo C, Anselmino M, Iacovino C, Palumbo L, Trevi GP, et al. (2010) Five year prognosis of an Italian cohort of juvenile acute myocardial infarction patients. Minerva Cardioangiol 58: 433-439.
35. O'Callaghan N, Dhillon V, Thomas P, Fenech M, (2008) A quantitative real-time PCR method for absolute telomere length. Biotechniques. 44: 807-809.
36. Slagboom PE, Droog S, Boomsma DI, (1994) Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet. 55: 876-82.
37. Frenck RW Jr, Blackburn EH, Shannon KM, (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A 95: 5607-10.